Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03590951 · ClinicalTrials.gov registry record
Anesthetic and Obstetric Outcomes in Morbidly Obese Pregnancy and Cesarean Delivery
A clinical trial, sponsored by Augusta University.
- Completed
- Registry status
- 771
- Enrollment target
NCT03590951: Completed study, sponsored by Augusta University.
NCT03590951 is a clinical trial that has completed, run by Augusta University. The registered enrollment target is 771 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03590951 has completed, sponsored by Augusta University.
- COMPLETED
- Registry status
- 771 participants
- Enrollment target
Study Summary
Given that morbid obesity has been strongly associated with obstetric, neonatal and anesthetic complications, and that scarce reports have evaluated anesthetic and obstetric outcomes after cesarean delivery in morbidly obese patients; This study retrospectively analyzed anesthetic, obstetric and neonatal outcomes in morbidly obese pregnant patients who underwent cesarean delivery at Augusta University Medical Center, during a 2-year period (2015-2016).
Primary Outcome
Perioperative bleeding
Interventions
- OTHER Retrospective chart review
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 771 participants |
| Start Date | 2017-05-03 |
| Est. Completion | 2018-02-13 |
What the finished NCT03590951 record still lists
NCT03590951 is an observational study that tracks outcomes without assigning an intervention. The registered 771 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Retrospective chart review is the first listed.
NCT03590951 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03590951 about?
NCT03590951 is a clinical study titled "Anesthetic and Obstetric Outcomes in Morbidly Obese Pregnancy and Cesarean Delivery". Given that morbid obesity has been strongly associated with obstetric, neonatal and anesthetic complications, and that scarce reports have evaluated anesthetic and obstetric outcomes after cesarean delivery in morbidly obese patients; This study retrospectively analyzed anesthetic, obstetric and neo...
What is the current status of trial NCT03590951?
This trial is currently completed. The enrollment target is 771 participants. The study started on 2017-05-03. Estimated completion is 2018-02-13.
What interventions are being tested in trial NCT03590951?
The interventions under investigation include: Retrospective chart review (OTHER).
Who is sponsoring clinical trial NCT03590951?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05977348 · 770 participants · NA
Increasing Food Literacy in Preschoolers to Reduce Obesity Risk
- NCT06376994 · 770 participants · Phase 3
Multi-Center Clean Air Randomized Controlled Trial in COPD
- NCT06824467 · 770 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
- NCT06907173 · 770 participants · Phase 3
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI